Oppenheimer Downgrades ORIC Pharmaceuticals to Perform

Oppenheimer analyst Kevin DeGeeter downgrades ORIC Pharmaceuticals (NASDAQ:ORIC) from Outperform to Perform.

Oppenheimer analyst Kevin DeGeeter downgrades ORIC Pharmaceuticals (NASDAQ:ORIC) from Outperform to Perform.

Total
0
Shares
Related Posts